Mycophenolate Sodium Enteric-Coated Tablets – For Laboratory Research Use Only

Mycophenolate Sodium Enteric-Coated Tablets – For Laboratory Research Use Only

(1 条用户评价)

$1.00

Ruiyirong Mycophenolate Sodium Enteric-Coated Tablets deliver 0.18g per tablet. Supplied in a 120-tablet bottle, approved under NMPA H20213232. For experimental research use only.?For wholesale prices, other specifications and uses, please consult our staff?

EMI starting from $0.00/month - View Plans
Compare
分类:

描述

Mycophenolate Sodium is an immunosuppressive agent used in scientific research to explore mechanisms of T- and B-cell proliferation inhibition, particularly in transplant immunology models and autoimmune disease studies.

This enteric-coated formulation by Chengdu Shengdi Pharmaceutical Co., Ltd. provides 0.18g of mycophenolate sodium per tablet, designed to ensure gastric bypass and targeted intestinal absorption, enhancing its reliability in pharmacokinetic and immunosuppressive studies.

This product is suitable for research labs requiring high-purity immunosuppressive materials. It meets NMPA regulatory standards under approval number H20213232 and is identified by the drug code 86980435000106.

Note: Strictly for research use only. Not intended for human or veterinary consumption.


Mycophenolate Sodium Enteric-Coated Product Specifications

Parameter Details
Product Name Mycophenolate Sodium Enteric-Coated Tablets (Ruiyirong)
Active Ingredient Mycophenolate Sodium
CAS Number 370868-04-9
Molecular Formula C17H19NaO6
Molecular Weight 342.32 g/mol
Strength 0.18g per tablet
Quantity per Bottle 120 tablets
Dosage Form Enteric-Coated Tablets
Approval Number H20213232 (China NMPA)
Product Code 86980435000106
Manufacturer Chengdu Shengdi Pharmaceutical Co., Ltd.
Barcode 6970071730073
Intended Use For laboratory research only
Storage Conditions Store in a cool, dry place below 25°C

Mycophenolate Sodium Enteric-Coated Mechanism of Action & Research Applications

Mycophenolate sodium is hydrolyzed in vivo to mycophenolic acid (MPA), which inhibits inosine monophosphate dehydrogenase (IMPDH). This action suppresses de novo purine synthesis, affecting lymphocyte proliferation.

Research Applications include:

  • Organ transplantation immunosuppression models

  • Autoimmune disease models (e.g., lupus, IBD)

  • In vitro lymphocyte proliferation studies

  • Pharmacokinetics and bioavailability trials


Mycophenolate Sodium Enteric-Coated Side Effects (For Reference Only in Models)

In research models, mycophenolate sodium may induce:

  • Gastrointestinal disturbances

  • Leukopenia or immunosuppression

  • Hepatic enzyme alterations

  • Teratogenic effects in developmental assays


Disclaimer

This product is intended solely for laboratory and experimental research. It is not intended for human or veterinary use. All research should follow institutional and national safety regulations.


其他信息

重量 1 公斤
尺寸 36 × 23 × 36 厘米

Mycophenolate Sodium Enteric-Coated Tablets – For Laboratory Research Use Only 有 1 个评价

  1. simonrusic

    The package was lost, you resent it, thank you

添加评价

您的邮箱地址不会被公开。 必填项已用 * 标注

Q1: What is the intended use of Mycophenolate Sodium Tablets?

A1: These tablets are used in research to study immunosuppressive mechanisms, particularly related to T-cell inhibition and transplant rejection. For research use only.

Q2: What makes the formulation enteric-coated?

A2: The enteric coating prevents dissolution in the stomach and ensures absorption in the intestines, enhancing bioavailability in experimental studies.

Q3: Is this product suitable for autoimmune disease research?

A3: Yes, it’s commonly used in research related to lupus, rheumatoid arthritis, and inflammatory bowel disease models.

Q4: Can I buy in bulk for institutional research?

A4: Yes. Both wholesale and retail orders are supported with volume discounts for research facilities.

Q5: What is the origin and manufacturer of this product?

A5: The product is manufactured by Chengdu Shengdi Pharmaceutical Co., Ltd., and complies with NMPA standards.

Q6: What is the CAS number for mycophenolate sodium?

A6: The CAS number is 370868-04-9.

Q7: How many tablets are in each package?

A7: Each package contains 120 tablets.

Q8: What storage conditions are required?

A8: Store below 25°C in a dry and cool environment.

Q9: Are COA and SDS available upon request?

A9: Yes. Certificate of Analysis (COA) and Safety Data Sheet (SDS) can be provided for research documentation.

Q10: Is this product safe for human use?

A10: No. This product is strictly intended for experimental and research use only.


EMI Options

Select at least 2 products
to compare